Terkko Navigator / -/ Feeds / " ( ( Statiinit )|( Statiini )|( HMG-KoA-reduktaasin estäjät )|( Hydroksimetyyliglutaryyl"

Statiinit suurentavat aivoverenvuodon vaaraa osalla potilaista– riski ei liity PCSK9:n estäjiin

Statiinit eivät ehkäise muistisairauksia

Monilääkityn tilanne heikkenee jos statiinit lopetetaan

Molecular basis of the effect of atorvastatin pretreatment on stem cell therapy in chronic ischemic diseases - critical limb ischemia

Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women.

HMG-CoA reductase inhibitors (Statins) and their Drug Interactions involving CYP enzymes, P-glycoprotein and OATP Transporters - An Overview.

HMG-CoA reductase inhibitors (Statins) and their Drug Interactions involving CYP enzymes, P-glycoprotein and OATP Transporters - An Overview

Statiinit voisivat ehkäistä verkkokalvoirtaumaan liittyvää haitallista arpimuodostusta

Statins and Abnormal Liver Function Tests: Is There a Correlation?

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.

Statins as Anticancer Agents in the Era of Precision Medicine

HMG-CoA Reductase as Target for Drug Development.

JCM, Vol. 11, Pages 1313: Antioxidant Effects of Statins by Modulating Nrf2 and Nrf2/HO-1 Signaling in Different Diseases

Immuno, Vol. 2, Pages 317-343: The Immunomodulatory Effects of Statins on Macrophages

Implications on the Therapeutic Potential of Statins via Modulation of Autophagy

Processes, Vol. 9, Pages 1085: A QM/MM Evaluation of the Missing Step in the Reduction Mechanism of HMG-CoA by Human HMG-CoA Reductase

Pharmaceuticals, Vol. 15, Pages 151: Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer

Molecules, Vol. 25, Pages 3891: An Atomic-Level Perspective of HMG-CoA-Reductase: The Target Enzyme to Treat Hypercholesterolemia

Potential natural inhibitors of xanthine oxidase and HMG-CoA reductase in cholesterol regulation: in silico analysis

Pharmacokinetic Comparison of the Potential Over-the-Counter Statins Simvastatin, Lovastatin, Fluvastatin and Pravastatin.

Pharmacokinetic Comparison of the Potential Over-the-Counter Statins Simvastatin, Lovastatin, Fluvastatin and Pravastatin.

Pharmacokinetic Comparison of the Potential Over-the-Counter Statins Simvastatin, Lovastatin, Fluvastatin and Pravastatin.

Drug interactions with HMG-CoA reductase inhibitors (statins): The importance of CYP enzymes, transporters and pharmacogenetic.

High vitreous concentration of vascular endothelial growth factor in diabetic patients with proliferative retinopathy using statins.

IJMS, Vol. 22, Pages 12198: A Possible Role for HMG-CoA Reductase Inhibitors and Its Association with HMGCR Genetic Variation in Parkinson’s Disease

IJERPH, Vol. 19, Pages 1370: Use of Statins in Kidney Transplant Recipients in Norway

A dual inhibitor targeting HMG-CoA reductase and histone deacetylase mitigates neurite degeneration in LRRK2-G2019S parkinsonism.

HMG-CoA reductase inhibitors (Statins) and their Drug Interactions involving CYP enzymes, P-glycoprotein and OATP Transporters - An Overview.

HMG-CoA reductase inhibitors (Statins) and their Drug Interactions involving CYP enzymes, P-glycoprotein and OATP Transporters - An Overview

Statiinit ja sepsis

Statiinit eivät ehkäise muistisairauksia

Statiinit suurentavat aivoverenvuodon vaaraa osalla potilaista– riski ei liity PCSK9:n estäjiin

Statiinit edistävät sepelvaltimoplakkien kalkkeutumista

Statiinit edistävät sepelvaltimoplakkien kalkkeutumista

Comparative Hepatic and Intestinal Metabolism and Pharmacodynamics of Statins

Comparative Hepatic and Intestinal Metabolism and Pharmacodynamics of Statins

Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase.

Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase.

Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase.

Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase.

Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase.

Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase.

Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase.

Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase.

Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase.

Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase.

Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase.

Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase

Structure-guided investigations into HMG-CoA reductase as a herbicide target

JCM, Vol. 11, Pages 3331: Implication of Lipids in Calcified Aortic Valve Pathogenesis: Why Did Statins Fail?